Overview

  • HOPE-2
    Keywords: HOPE 2, MDA, DMD, Clinical Trial , Duchenne, Placebo-Controlled
    Specialties: Neurology,Neurology, Muscular Dystrophy,null,
    Status: Not yet recruiting Principal Investigator: Russell Butterfield
  • CCTN - Oral Contraceptive (UPA)
    Keywords: birth control pill, ulipristal, contraception
    Specialties: OB/Gyn, General,OB/Gyn, General,OB/Gyn, General, Gynecology,Women's Health,Contraception and Family Planning,
    Status: Recruiting Principal Investigator: David Turok
  • CCTN Vaginal Ring
    Keywords: Family Planning, Contraception, Birth Control
    Specialties: OB/Gyn, General, Women's Health,
    Status: Completed Principal Investigator: David Turok
  • CCTN - Copper IUD Comparison
    Keywords: Contraception, IUD, Birth Control
    Specialties: OB/Gyn, General,OB/Gyn, General, Gynecology,Contraception and Family Planning,
    Status: Recruiting Principal Investigator: David Turok
  • A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
    Keywords: Long Term Birth Control, Birth Control, IUD
    Specialties: OB/Gyn, General, Obstetrics,
    Status: Completed Principal Investigator: David Turok
  • Advancing Telestroke Care
    Keywords: Ischemic Stroke, Outcome, Telemedicine, Control
    Specialties: Neurology, Stroke,
    Status: Active, not recruiting Principal Investigator: Jennifer Majersik
  • E4 Freedom
    Keywords: Oral Birth Control Pill, Birth Control Pill
    Specialties: OB/Gyn, General,OB/Gyn, General, Gynecology,Women's Health,
    Status: Recruiting Principal Investigator: Lori Gawron
  • CRD3003 - IMUNITI
    Keywords: CNTO1275CRD3003: A phase 3, randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of Ustekinumab maintenance therapy in subjects with moderately to severely active crohn's disease.
    Specialties: Gastroenterology, Irritable Bowel Syndrome,
    Status: Active, not recruiting Principal Investigator: Kathryn Peterson